电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant CD37 (Naratuximab Biosimilar) 抗体

Research Grade 适用: 人 ELISA, WB 宿主: Humanized Chimeric unconjugated Recombinant Antibody
产品编号 ABIN7538072
发货至: 中国
  • 抗原 See all CD37 (Naratuximab Biosimilar) products
    CD37 (Naratuximab Biosimilar)
    抗体类型
    Recombinant Antibody
    适用
    宿主
    • 1
    Humanized
    Expression System
    Mammalian cells
    克隆类型
    • 1
    Chimeric
    标记
    • 1
    This CD37 (Naratuximab Biosimilar) antibody is un-conjugated
    应用范围
    ELISA, Western Blotting (WB)
    原理
    Naratuximab Biosimilar – Anti-CD37 mAb - Research Grade
    产品特性
    Antibody Type: IgG1-kappa
    纯化方法
    Recombinant antibody expressed in mammalien cells and purified.
    纯度
    > 85%
    质量等级
    Research Grade
    亚型
    IgG1 kappa
  • 限制
    仅限研究用
  • 缓冲液
    PBS buffer PH7.5
    储存条件
    -80 °C
    储存方法
    store at -80°C
  • 抗原
    CD37 (Naratuximab Biosimilar)
    Abstract
    CD37 (Naratuximab Biosimilar) 产品
    背景
    Naratuximab is a humanized monoclonal antibody that binds CD37. Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine.
    CAS-编号
    1622327-39-2
You are here:
客服